This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
UP against younger, faster and equally skilled counterparts, former PBA champion Denok Miranda believes he needs to work double time and be in tip-top condition once he plunges to action in the MPBL Datu Cup.
Just when people criticized Gilas Pilipinas for giving in to their tempers which triggered the bench-clearing brawl against Australia at the Fiba World Cup Qualifier match on Monday, July 2, Queen of All Media Kris Aquino expressed her intentions of befriending Gilas player Terrence Romeo for his bold stance at standing by his team all throughout.
THE Philippine U19 men’s national football team is stepping up its preparation as it competes in the ASEAN Football Federation men’s championship in July in Indonesia.
“At what point has it become alright for our people to stop defending human rights and, instead, start condemning it and its defenders?”
Environment Secretary Roy Cimatu congratulates the DENR employees who passed the 2017 Bar examinations. In photo are (from left) lawyers Wendell Caoagas, Andrea Victoria Amog, Jiana Joselle de Guzman, Fatima Angeli Tan and Lovely Grazette Quiben. Contibuted photo
“Heritage advocacy has become glamorous, thanks to Toti Villalón,” said Villalón’s colleague, Unesco National Commission’s Eric Zerrudo. —PHOTO FROM PHILIPPINE TATLER
SHE finished her University Athletic Association of the Philippines (UAAP) career sans a championship to show for but Far Eastern University (FEU) star Bernadeth Pons said her collegiate journey was worthwhile and that she is leaving it a winner.
Nick Joaquin wrote about Calle Morayta in old Sampaloc, Manila, thus: “Remember Catalina Zandueta when she played a gorgeous Aida? Or the really heartbreaking ‘Madame Butterfly’ of Dalisay Aldaba? Or the great Alexandra Danilova dancing the ‘Dying Swan?’ Or the Manila Symphony Orchestra in concert doing the ‘Brahms No. 2’? Or the premiere of Leonor Orosa’s ‘Noli Dance Suite’ (“Salome, Sisa, Maria Clara”)? Or Alfredo Lozano or José Cubiles, to play Beethoven’s ‘Appassionata’? Or everyone’s astonishment when Martha Graham displayed her ballet à la mode? Or Remedios Bosch Jimenez singing Leonora to Arrigo Pola’s ‘Trovatore?’”
Augusto Villalón, architect and cultural heritage conservation advocate who spearheaded the listing of several Philippine historical and natural landmarks in the very prestigious World Heritage List of the United Nations Educational, Scientific, Cultural Organization (Unesco), has passed away today (May 5) after a lingering illness following a stroke.
THE De La Salle Lady Spikers further underscored their “gold standard” status in University Athletic Association of the Philippines (UAAP) women’s volleyball after completing another three-peat with a sweep of the Far Eastern University (FEU) Lady Tamaraws in their best-of-three Season 80 finals yesterday at the Smart Araneta Coliseum.
INTERNATIONAL beach volleyball action descends on the country starting today with the FIVB Beach Volleyball World Tour Manila Open kicking off at The Sands SM By The Bay.
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...